- Home
- GRAL vs NDMO Comparison
GRAL vs NDMO Comparison
Compare GRAL & NDMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRAL
- NDMO
- Stock Information
- Founded
- GRAL 2016
- NDMO 2019
- Country
- GRAL United States
- NDMO United States
- Employees
- GRAL N/A
- NDMO N/A
- Industry
- GRAL
- NDMO Trusts Except Educational Religious and Charitable
- Sector
- GRAL
- NDMO Finance
- Exchange
- GRAL NYSE
- NDMO Nasdaq
- Market Cap
- GRAL 1.3B
- NDMO N/A
- IPO Year
- GRAL N/A
- NDMO N/A
- Fundamental
- Price
- GRAL $47.56
- NDMO $10.21
- Analyst Decision
- GRAL Buy
- NDMO
- Analyst Count
- GRAL 3
- NDMO 0
- Target Price
- GRAL $31.50
- NDMO N/A
- AVG Volume (30 Days)
- GRAL 1.5M
- NDMO 218.6K
- Earning Date
- GRAL 08-12-2025
- NDMO 01-01-0001
- Dividend Yield
- GRAL N/A
- NDMO 6.75%
- EPS Growth
- GRAL N/A
- NDMO N/A
- EPS
- GRAL N/A
- NDMO N/A
- Revenue
- GRAL $130,711,000.00
- NDMO N/A
- Revenue This Year
- GRAL $19.52
- NDMO N/A
- Revenue Next Year
- GRAL $20.37
- NDMO N/A
- P/E Ratio
- GRAL N/A
- NDMO N/A
- Revenue Growth
- GRAL 30.47
- NDMO N/A
- 52 Week Low
- GRAL $12.33
- NDMO $8.99
- 52 Week High
- GRAL $63.99
- NDMO $11.24
- Technical
- Relative Strength Index (RSI)
- GRAL N/A
- NDMO 60.93
- Support Level
- GRAL N/A
- NDMO $9.95
- Resistance Level
- GRAL N/A
- NDMO $10.04
- Average True Range (ATR)
- GRAL 0.00
- NDMO 0.10
- MACD
- GRAL 0.00
- NDMO 0.01
- Stochastic Oscillator
- GRAL 0.00
- NDMO 65.00
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.